The Coca-Cola Company to Attend Redburn CEO Conference.

  The Coca-Cola Company to Attend Redburn CEO Conference. The Giant King  of Beverage announced last week that President and CEO James Quincey will attend the Redburn CEO Conference on December 1 at 11am ET. The Company announced last week that President and CEO James Quincey will attend the Redburn CEO Conference on December 1 at 11am ET. Thus, the Company invited investors to participate in the webcast of the event at www.coca-colacompany.com/investors. And even a downloadable file and a transcript will be available on the company's website within 24 hours of the event, he added.

Information About The Coca-Cola Company.

Company KO (NYSE) $55,91 -0,31 (-%0,55) as it is known, is a full-fledged beverage company whose products are sold in more than 200 countries and territories. Management explained that the purpose of the Company is to renew the world and make a difference, as well as to sell more than one billion dollars of brands in various beverage categories worldwide.

The Coca-Cola Company to Attend Redburn CEO Conference.

Its portfolio includes sparkling soft drink brands Coca-Cola, Sprite and Fanta, Hydration products include Dasani, smartwater, vitaminwater, Topo Chico, Powerade, Costa, Georgia, Gold Peak, Honest and Ayataka brands for sports, coffee and tea, and Minute Maid, Simple, innocent, Del Valle, Fairlife and AdeS brands for nutrition products. They announced that they are constantly transforming their portfolios, from reducing sugar in their beverages to introducing innovative new products to the market. They explained that they are working to positively impact people's lives, communities and the planet by reducing water supply, packaging recycling, sustainable sourcing practices and reducing carbon emissions across value chains. They added that, together with their bottling partners, they employ more than 700,000 people, thereby helping to bring economic opportunities to local communities around the world.  

Source: Yahoo.Finance

You may also be interested in:

Pfizer: Bull Market vs. Bear Market